loadpatents
Patent applications and USPTO patent grants for Jimeno; Jose.The latest application filed is for "use of aplidine for the treatment of pancreatic cancer".
Patent | Date |
---|---|
Pharmaceutical formulation of a didemnin compound Grant 8,420,130 - Nuijen , et al. April 16, 2 | 2013-04-16 |
Compositions and uses of ET743 for treating cancer Grant 8,119,638 - Cvitkovich , et al. February 21, 2 | 2012-02-21 |
Use of Aplidine for the Treatment of Pancreatic Cancer App 20100041594 - Mangues; Ramon ;   et al. | 2010-02-18 |
Antitumoral Treatments App 20090227490 - Bertino; Joseph R. ;   et al. | 2009-09-10 |
Antitumoral treatments Grant 7,576,188 - Bertino , et al. August 18, 2 | 2009-08-18 |
Compositions and Uses of Et 743 for Treating Cancer App 20070275942 - Cvitkovich; Esteban ;   et al. | 2007-11-29 |
Antitumoral treatments App 20060178298 - Bertino; JosephR ;   et al. | 2006-08-10 |
Kahalalide compounds for use in cancer therapy App 20050054555 - Jimeno, Jose ;   et al. | 2005-03-10 |
Use of antitumoral compound in cancer therapy App 20050004018 - Jimeno, Jose ;   et al. | 2005-01-06 |
Use of aplidine for the treatment of pancreatic cancer App 20050004012 - Mangues, Ramon ;   et al. | 2005-01-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.